Stocks making the biggest moves after hours: BOK Financial, Medpace, Zions Bancorporation, MongoDB and more

These are the stocks posting the largest moves in after-hours trading. #Stocks #making #biggest #moves #hours #BOK #Financial #Medpace #Zions #Bancorporation #MongoDB

https://10bmnews.com/2025/04/stocks-making-the-biggest-moves-after-hours-bok-financial-medpace-zions-bancorporation-mongodb-and-more/

Stocks making the biggest moves after hours: BOK Financial, Medpace, Zions Bancorporation, MongoDB and more - 10bmnews

These are the stocks posting the largest moves in after-hours trading. #Stocks #making #biggest #moves #hours #BOK #Financial #Medpace #Zions #Bancorporation #MongoDB

10bmnews -

🔍 Medpace Careers 2025 🔍

💼 Job Role: Software QA Test Engineer

🔗 https://studentscircles.com/medpace-careers/

💬 Join Our WhatsApp Group: https://bit.ly/waalerts

#jobs #hiring #freshers #offcampus #jobalert #jobsearch #entryleveljobs #studentscircles #medpace

Medpace Careers 2025 | Software QA Test Engineer

Unlock Your Career With Medpace Off Campus Drive, Medpace Recruitment, Medpace Careers, Medpace Internship, Medpace Walk-in Drive and More

Students Circles

Medpace Holdings, Inc. Common Stock (MEDP) Q2 2022 Earnings Call Transcript | The Motley Fool

Link📌 Summary:

Medpace Holdings, Inc. Common Stock (MEDP) Q2 2022 Earnings Call Transcript

The Motley Fool提供的這份會議電話逐字稿,內容涵蓋了公司第二季的財務表現、營運展望及其他相關資訊。

🎯 Key Points:

Medpace Q2 2022的總收入為$351.2億美元,較去年同期增加26.2%。
Q2 2022的淨新業務合同入庫金額為$450.6億美元,較去年同期增加16.3%。
Q2 2022的EBITDA為$68.1億美元,較去年同期增加42%。
Q2 2022的淨利潤為$49.4億美元,較去年同期增加23.6%。
2022年全年收入預計在$1.405億美元至$1.435億美元之間,年增率為23%至25.6%。
2022年全年EBITDA預計在$268億美元至$280億美元之間,年增率為20.1%至25.5%。

🔖 Keywords: #Medpace #Q2 #2022 #EarningsCall #Revenue #EBITDA #NetIncome #Guidance #Hiring #Retention #Costs #Debt #FreeCashFlow #BadDebt #ClinicalTrials

Medpace Holdings, Inc. Common Stock (MEDP) Q2 2022 Earnings Call Transcript

MEDP earnings call for the period ending June 30, 2022.

The Motley Fool

Here are some examples:

Ohio billionaire #AugustTroendle, CEO of #Medpace, repeatedly bought and sold shares of $Syneos - his company's archrival, timing the transactions with a management shakeup that dropped the stock by 16% in one day, and an SEC investigation that crushed Syneos's stock by 25%. His precision timing made him at least $2.3m in profit.

12/